About 128 ICG
Event Calendar
Focus on Innovation
Sponsors & Affiliates
Behind the Scenes
128 Venture North
Contact Information
Welcome to the 128 Innovation Capital Group
The 128 Innovation Capital Group has been meeting continuously for over 25 years, fulfilling its mission of fostering an environment where innovation flourishes. The 128 Innovation Capital Group provides the forum where Entrepreneurs can meet Investors, Talented and Experienced Managers and Service Providers who will enable their organizations to become successful enterprises.
Upcoming Events

Thursday, February 11, 2010
7:15 - 10:00 AM
Best Western TLC, Waltham, MA

Dana Callow, Boston Millennia Partners
2008/2009 - A Watershed Event - Where do We Go From Here?

Register for this event and pay by Credit Card
Register for this event and pay at the door.

Dana Callow is the Managing Partner of Boston Millennia Partners. Prior to founding Boston Millennia Partners, Dana co-founded Boston Capital Ventures in 1982. Before that, he worked as a Senior Consultant at Braxton Associates, an international strategic planning firm that was formed by professionals from Boston Consulting Group and Bain & Co. He worked with Fortune 100 companies in strategic planning and implementing merger and acquisition strategies.

Prior to working in the management consulting business, Dana worked in sales and marketing for Tymshare, Inc. (McDonnell-Douglas). He currently is Presiding Director and Chair of the governance committee of PAREXEL International Corporation (NasdaqGS:PRXL) a $1 billion plus clinical trials management company. He is, or has served, as a Director of a number of other public and private companies, including ILEX Oncology, Inc. (Nasdaq: ILXO), a cancer pharmaceutical company acquired by Genzyme for $1 billion; MedAptus, Inc., a mobile computing provider of clinical, financial and administrative software solutions to the medical community; and PHT Technologies, Inc., a provider of mobile and Web-based technology solutions to the pharmaceutical industry focused on clinical trials management. Other investment responsibilities included Glycofi Inc., (acquired by Merck, NYSE: MRK); HotJobs, Inc. (acquired by Yahoo, NasdaqGS: YHOO); iVillage, Inc. (acquired by NBC Universal, a subsidiary of General Electric, NYSE: GE); and Tektagen, Inc. (acquired by Charles River Laboratories, NYSE: CRL).

Dana is a Director of Jobs for Massachusetts, a Massachusetts based non-profit organization comprised of business and political leaders including the Governor and Congressional leaders. He is a member of the Advisory Board of the Dartmouth/Tuck Center for Private Equity and Entrepreneurship. He is a member of the Board of Trustees and the Chairman of the Investment Committee at Tufts University and on the Board of Overseers at Tufts University Medical School.

Dana is a magna cum laude graduate of Tufts University and holds an MBA from the Amos Tuck School at Dartmouth College



Thursday, February 18, 2010
4:00 -5:15 PM

A Blitztime Event:

Afarin Bellisario of Transtrategy, Inc.
Strategies on Commercializing Innovation


Register for this event

Good ideas are cheap. There's a big gap between having a great idea, or patent, or process and finally making money from it. Afarin Bellisario of Transtrategy, Inc. will discuss how to close that gap.

There is no charge from the 128 Innovation Capital Group to attend this virtual event. There may be a charge from BlitzTime.

Our Meetings
At meetings, attendees are identified as Investors seeking new investment opportunities, Entrepreneurs looking for investment in their ventures, Management Candidates searching for new opportunities or Service Providers looking to provide help and services to all.  

Fees are $45 for Entrepreneurs and Management Candidates and $55 for Investors and Service Providers. Learn More

Check out our blog! Learn More

Privacy Policy | Contact Us | Register | 128ICG Blog |
128 Innovation Capital Group 315 Lake St. Waltham, MA 02451 617.306.2906
© 2008 128 Innovation Capital Group All Rights Reserved